Evidence map›Paper›PMID 23919265›Full record

ArticleOrphanet journal of rare diseases2013

Genotype-phenotype correlations in recessive RYR1-related myopathies.

Kimberly Amburgey, Angela Bailey, Jean H Hwang, Mark A Tarnopolsky, Carsten G Bonnemann, Livija Medne, Katherine D Mathews, James Collins, Jasper R Daube, Gregory P Wellman and 3 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. BioMed research international · 2019
    Trial
  3. Trial
  4. Article
  5. The Clinical, Histological, and Genetic Spectrum ofJournal of clinical medicine · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Compound HeterozygousInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Rycal S48168 (ARM210) forEClinicalMedicine · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Kimberly AmburgeyDepartment of Pediatrics, Taubman Medical Research Institute, University of Michigan Medical Center, 5019 A, Alfred Taubman Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA.
Angela Bailey
Jean H Hwang
Mark A Tarnopolsky
Carsten G Bonnemann
Livija Medne
Katherine D Mathews
James Collins
Jasper R Daube
Gregory P Wellman
Brian Callaghan
Nigel F Clarke
James J Dowling
University of Michigan–Ann Arbor · USA. Alfred Taubman Health Care Center · USChildren's Hospital at Westmead · AUChildren's Hospital of Philadelphia · USCincinnati Children's Hospital Medical Center · USDelta Air Lines (United States) · USMcMaster University Medical Centre · CANational Institutes of Health · USUniversity of Iowa · USUniversity of Sydney · AU

Funding

Molecular and Clinical Manifestations of Matrix and Aggregate MyopathiesZIANS003129 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BÖNNEMANN, CARSTEN · 2011 to 2025
$52.8M
Myotubularin and the Pathogenesis of Myotubular MyopathyK08AR054835 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOWLING, JAMES J · 2009 to 2013
$640k
NIAMS NIH HHS K08AR054835
6 · The paper itself

Abstract

backgroundRYR1 mutations are typically associated with core myopathies and are the most common overall cause of congenital myopathy. Dominant mutations are most often associated with central core disease and malignant hyperthermia, and genotype-phenotype patterns have emerged from the study of these mutations that have contributed to the understanding of disease pathogenesis. The recent availability of genetic testing for the entire RYR1 coding sequence has led to a dramatic expansion in the identification of recessive mutations in core myopathies and other congenital myopathies. To date, no clear patterns have been identified in these recessive mutations, though no systematic examination has yet been performed.

methodsIn this study, we investigated genotype-phenotype correlations in a large combined cohort of unpublished (n = 14) and previously reported (n = 92) recessive RYR1 cases.

resultsOverall examination of this cohort revealed nearly 50% of cases to be non-core myopathy related. Our most significant finding was that hypomorphic mutations (mutations expected to diminish RyR1 expression) were enriched in patients with severe clinical phenotypes. We also determined that hypomorphic mutations were more likely to be encountered in non-central core myopathies. With analysis of the location of non-hypomorphic mutations, we found that missense mutations were generally enriched in the MH/CCD hotspots and specifically enriched in the selectivity filter of the channel pore.

conclusionsThese results support a hypothesis that loss of protein function is a key predictive disease parameter. In addition, they suggest that decreased RyR1 expression may dictate non-core related pathology though, data on protein expression was limited and should be confirmed in a larger cohort. Lastly, the results implicate abnormal ion conductance through the channel pore in the pathogenesis in recessive core myopathies. Overall, our findings represent a comprehensive analysis of genotype-phenotype associations in recessive RYR1-myopathies.

Indexed as

Genes, RecessiveGenetic Association StudiesMutationCohort StudiesFemaleHumansMaleMuscular DiseasesRyanodine Receptor Calcium Release ChannelSeverity of Illness IndexRyanodine Receptor Calcium Release Channel

Identifiers

PMID23919265
PMCPMC3751094
OpenAlexW2152064075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.